About Marisa

Dr. Marisa Gremigni is the founder of Keystone Biotech Consulting and a global CMC and Technical Operations leader with 18 years of experience advancing complex biologics, vaccines, and innovative therapies from early development through commercial launch. Her career spans senior roles at Anthos Therapeutics, Novartis Pharmaceuticals, Novartis Vaccines, GSK Vaccines, and bioMérieux, where she oversaw CMC strategy portfolio, technology transfers, manufacturing scale-up, and commercial readiness across international markets — consistently driving alignment across development, quality, regulatory, and supply chain functions. Through Keystone, she brings this depth of experience directly to biotech companies building stage-appropriate CMC strategies and reliable supply chains.